- Home
- ISRG vs TMO Comparison
ISRG vs TMO Comparison
Compare ISRG & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISRG
- TMO
- Stock Information
- Founded
- ISRG 1995
- TMO 1956
- Country
- ISRG United States
- TMO United States
- Employees
- ISRG N/A
- TMO N/A
- Industry
- ISRG Medical/Dental Instruments
- TMO Industrial Machinery/Components
- Sector
- ISRG Health Care
- TMO Industrials
- Exchange
- ISRG Nasdaq
- TMO Nasdaq
- Market Cap
- ISRG 185.9B
- TMO 203.5B
- IPO Year
- ISRG 2000
- TMO N/A
- Fundamental
- Price
- ISRG $592.64
- TMO $559.73
- Analyst Decision
- ISRG Strong Buy
- TMO Buy
- Analyst Count
- ISRG 20
- TMO 19
- Target Price
- ISRG $540.89
- TMO $646.58
- AVG Volume (30 Days)
- ISRG 1.6M
- TMO 1.8M
- Earning Date
- ISRG 01-23-2025
- TMO 01-30-2025
- Dividend Yield
- ISRG N/A
- TMO 0.28%
- EPS Growth
- ISRG 46.29
- TMO 4.56
- EPS
- ISRG 6.22
- TMO 15.95
- Revenue
- ISRG $7,866,900,000.00
- TMO $42,370,000,000.00
- Revenue This Year
- ISRG $16.56
- TMO $0.85
- Revenue Next Year
- ISRG $16.85
- TMO $4.85
- P/E Ratio
- ISRG $95.32
- TMO $35.08
- Revenue Growth
- ISRG 14.83
- TMO N/A
- 52 Week Low
- ISRG $362.14
- TMO $493.30
- 52 Week High
- ISRG $597.68
- TMO $627.88
- Technical
- Relative Strength Index (RSI)
- ISRG 72.55
- TMO 65.20
- Support Level
- ISRG $530.25
- TMO $544.06
- Resistance Level
- ISRG $550.18
- TMO $563.81
- Average True Range (ATR)
- ISRG 13.57
- TMO 12.07
- MACD
- ISRG 6.17
- TMO 3.67
- Stochastic Oscillator
- ISRG 93.51
- TMO 89.30
About ISRG Intuitive Surgical Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).